Charles River Laboratories Intl. Inc vs New Era Energy & Digital Inc. Common Stock — how do they compare? Charles River Laboratories Intl. Inc trades at $301.4 (market cap $14.23B), while New Era Energy & Digital Inc. Common Stock trades at $4.7 (market cap $583.45M). The key difference: Charles River Laboratories Intl. Inc is far larger — about 24.4× New Era Energy & Digital Inc. Common Stock's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, New Era Energy & Digital Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and New Era Energy & Digital Inc. Common Stock for 0 Days on average.
| CRL | NUAI | |
|---|---|---|
Market Cap | $14.23B | $583.45M |
Volume | 1,176,885 | 17,217,412 |
Sector | Health | Technology |
52-Week High | $310.77 | $8.06 |
52-Week Low | $149.93 | $2.35 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $17.06B | $528.80M |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.
Read more on NUAI →